Company Overview
About Mendel
Mendel is a clinical trial data management and AI platform that accelerates pharmaceutical and biotech drug development by extracting structured insights from unstructured medical records — physician notes, pathology reports, lab results, and clinical documentation — using natural language processing to identify patients eligible for trials, adverse events, and endpoint assessments. Founded in 2017 and headquartered in San Francisco, Mendel raised approximately $35 million and serves life sciences companies, hospital systems, and CROs (contract research organizations) running clinical trials.
Business Model & Competitive Advantage
Mendel's platform applies clinical NLP to free-text medical records to extract structured data that standard coding and form-based data capture misses — a physician's note about a patient's symptom progression, a mention of prior therapy failure in a consultation note, or a pathology finding that determines trial eligibility. This extracted data enables more accurate patient matching for clinical trial recruitment, pharmacovigilance (detecting safety signals in real-world patient records), and evidence generation from real-world data.
Competitive Landscape 2025–2026
In 2025, Mendel operates in the clinical AI and real-world evidence (RWE) market alongside companies like Komodo Health, Veeva Systems, Medidata (Dassault Systèmes), and Tempus for different aspects of clinical data management. The life sciences industry faces significant pressure to accelerate drug development timelines, and AI-powered clinical data extraction is viewed as a key lever for improving trial efficiency and reducing costly recruitment failures. Mendel's 2025 strategy focuses on expanding its FDA submission-ready data extraction capabilities, deepening oncology clinical trial applications where complex biomarker data requires sophisticated NLP, and growing its real-world evidence generation platform.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Mendel is an established challenger with significant market presence and competitive offerings in Healthcare.
Frequently Asked Questions
Not So Random Others
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Compare Mendel with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Mendel? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Mendel Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Mendel vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →